Mobile Menu - OpenMobile Menu - Closed

Hearing on “Examining HRSA’s Oversight of the 340B Drug Pricing Program,” Subcommittee on Oversight and Investigations (July 18, 2017)

Date: 
Tuesday, July 18, 2017 - 10:15am
Location: 
2322 Rayburn House Office Building

The Subcommittee on Oversight and Investigations held a hearing on Tuesday, July 18, 2017, at 10:15 a.m. in 2322 Rayburn House Office Building.  The hearing is entitled “Examining HRSA’s Oversight of the 340B Drug Pricing Program.”

 

Livestream

 

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Oversight and Investigations

Opening Statement of Ranking Member Pallone as prepared for delivery

 

Witnesses

Krista M. Pedley, PharmD, MS, Captain, USPHS
Director
Office of Pharmacy Affairs
Health Resources and Services Administration
U.S. Department of Health and Human Services

Testimony

 

Debra Draper
Director, Health Care
U.S. Government Accountability Office

Testimony

 

Erin Bliss
Assistant Inspector General
Office of Evaluation and Inspections
Office of Inspector General
U.S. Department of Health and Human Services

Testimony

 

Issues: